• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-8与胶质母细胞瘤中的促血管生成和间充质亚型相关。

IL-8 associates with a pro-angiogenic and mesenchymal subtype in glioblastoma.

作者信息

Conroy Siobhan, Kruyt Frank A E, Wagemakers Michiel, Bhat Krishna P L, den Dunnen Wilfred F A

机构信息

Department of Pathology and Medical Biology, Division of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Department of Translational Molecular Pathology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.

出版信息

Oncotarget. 2018 Feb 28;9(21):15721-15731. doi: 10.18632/oncotarget.24595. eCollection 2018 Mar 20.

DOI:10.18632/oncotarget.24595
PMID:29644004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5884659/
Abstract

Glioblastoma (GBM) is a highly aggressive brain tumor characterized by a high rate of vascularization. However, therapeutic targeting of the vasculature through anti-vascular endothelial growth factor (VEGF) treatment has been disappointing, for which Angiopoietin-2 (Ang-2) upregulation has partly been held accountable. In this study we therefore explored the interplay of Ang-2 and VEGFA and their effect on angiogenesis in GBM, especially in the context of molecular subclasses. In a large patient cohort we identified that especially combined high expression of Ang-2 and VEGFA predicted poor overall survival of GBM patients. The high expression of both factors was also associated with increased IL-8 expression in GBM tissues, but stimulation with Ang-2 and/or VEGFA did not indicate tumor or endothelial cell-specific IL-8 responses. Glioblastoma stem cells (GSCs) of the mesenchymal (MES) subtype showed dramatically higher expression of IL8 when compared to proneural (PN) GSCs. Secreted IL-8 derived from MES GSCs induced endothelial proliferation and tube formation, and the MES GBMs had increased counts of proliferating endothelial cells. Our results highlight a critical pro-angiogenic role of IL-8 in MES GBMs.

摘要

胶质母细胞瘤(GBM)是一种高度侵袭性的脑肿瘤,其特征是血管化程度高。然而,通过抗血管内皮生长因子(VEGF)治疗对脉管系统进行治疗靶向一直令人失望,血管生成素-2(Ang-2)上调在一定程度上对此负有责任。因此,在本研究中,我们探讨了Ang-2和VEGFA的相互作用及其对GBM中血管生成的影响,特别是在分子亚类的背景下。在一个大型患者队列中,我们发现特别是Ang-2和VEGFA的联合高表达预示着GBM患者的总体生存率较差。这两种因子的高表达也与GBM组织中IL-8表达增加有关,但用Ang-2和/或VEGFA刺激并未显示出肿瘤或内皮细胞特异性的IL-8反应。与神经干细胞样(PN)胶质母细胞瘤干细胞(GSCs)相比,间充质(MES)亚型的胶质母细胞瘤干细胞显示出显著更高的IL8表达。源自MES GSCs的分泌型IL-8诱导内皮细胞增殖和管形成,并且MES GBMs中增殖内皮细胞的数量增加。我们的结果突出了IL-8在MES GBMs中的关键促血管生成作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117a/5884659/e9ed091a8399/oncotarget-09-15721-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117a/5884659/274665f813fe/oncotarget-09-15721-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117a/5884659/23f6a3f25c95/oncotarget-09-15721-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117a/5884659/bddbd678ed12/oncotarget-09-15721-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117a/5884659/58f8470cdfb1/oncotarget-09-15721-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117a/5884659/e9ed091a8399/oncotarget-09-15721-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117a/5884659/274665f813fe/oncotarget-09-15721-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117a/5884659/23f6a3f25c95/oncotarget-09-15721-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117a/5884659/bddbd678ed12/oncotarget-09-15721-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117a/5884659/58f8470cdfb1/oncotarget-09-15721-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117a/5884659/e9ed091a8399/oncotarget-09-15721-g005.jpg

相似文献

1
IL-8 associates with a pro-angiogenic and mesenchymal subtype in glioblastoma.白细胞介素-8与胶质母细胞瘤中的促血管生成和间充质亚型相关。
Oncotarget. 2018 Feb 28;9(21):15721-15731. doi: 10.18632/oncotarget.24595. eCollection 2018 Mar 20.
2
Molecular subtypes and differentiation programmes of glioma stem cells as determinants of extracellular vesicle profiles and endothelial cell-stimulating activities.胶质瘤干细胞的分子亚型和分化程序作为细胞外囊泡谱和内皮细胞刺激活性的决定因素
J Extracell Vesicles. 2018 Jul 17;7(1):1490144. doi: 10.1080/20013078.2018.1490144. eCollection 2018.
3
Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients.过氧化物酶体增殖物激活受体 γ 作为间充质型神经胶质瘤患者的治疗靶点。
Exp Mol Med. 2020 Apr;52(4):629-642. doi: 10.1038/s12276-020-0413-1. Epub 2020 Apr 13.
4
Stem cell signature in glioblastoma: therapeutic development for a moving target.胶质母细胞瘤中的干细胞特征:针对动态靶点的治疗进展
J Neurosurg. 2015 Feb;122(2):324-30. doi: 10.3171/2014.9.JNS132253. Epub 2014 Nov 14.
5
Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses.胶质母细胞瘤亚类中血管生成模式和血管生成因子的新见解。
J Neurooncol. 2017 Jan;131(1):11-20. doi: 10.1007/s11060-016-2269-8. Epub 2016 Sep 15.
6
Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.基因表达谱分析可区分神经干细胞样胶质瘤干细胞与间充质胶质瘤干细胞。
Genom Data. 2015 Sep 1;5:333-336. doi: 10.1016/j.gdata.2015.07.007.
7
Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.多形性胶质母细胞瘤中增殖血管细胞p53突变的检测
J Neurosurg. 2015 Feb;122(2):317-23. doi: 10.3171/2014.10.JNS132159. Epub 2014 Nov 21.
8
Dihydropyrimidinase-related protein 5 controls glioblastoma stem cell characteristics as a biomarker of proneural-subtype glioblastoma stem cells.二氢嘧啶酶相关蛋白5作为神经干细胞样亚型胶质母细胞瘤干细胞的生物标志物,控制着胶质母细胞瘤干细胞的特征。
Oncol Lett. 2020 Aug;20(2):1153-1162. doi: 10.3892/ol.2020.11668. Epub 2020 May 22.
9
Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.人胶质母细胞瘤中血管生成及血小板衍生生长因子C(PDGF-C)、血管内皮生长因子(VEGF)、CD105和缺氧诱导因子-1α(HIF-1α)的表达
Neuropathology. 2014 Aug;34(4):343-52. doi: 10.1111/neup.12111. Epub 2014 Feb 26.
10
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.PATZ1是胶质母细胞瘤的一种新的预后标志物,与干细胞样表型相关,且在神经干细胞亚型中富集。
Oncotarget. 2017 Jul 25;8(35):59282-59300. doi: 10.18632/oncotarget.19546. eCollection 2017 Aug 29.

引用本文的文献

1
Prognostic signature detects homologous recombination deficient in glioblastoma.预后特征检测胶质母细胞瘤中的同源重组缺陷。
Transl Cancer Res. 2024 Nov 30;13(11):5883-5897. doi: 10.21037/tcr-23-2077. Epub 2024 Nov 21.
2
Emerging immunologic approaches as cancer anti-angiogenic therapies.新兴的免疫疗法作为癌症抗血管生成治疗手段。
Clin Transl Oncol. 2025 Apr;27(4):1406-1425. doi: 10.1007/s12094-024-03667-2. Epub 2024 Sep 18.
3
Novel Function of Cancer Stem Cell Marker ALDH1A3 in Glioblastoma: Pro-Angiogenesis through Paracrine PAI-1 and IL-8.

本文引用的文献

1
Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses.胶质母细胞瘤亚类中血管生成模式和血管生成因子的新见解。
J Neurooncol. 2017 Jan;131(1):11-20. doi: 10.1007/s11060-016-2269-8. Epub 2016 Sep 15.
2
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival.血管生成素-2/血管内皮生长因子双特异性抗体将巨噬细胞和常驻小胶质细胞重编程为抗肿瘤表型,并延长胶质母细胞瘤患者的生存期。
Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4476-81. doi: 10.1073/pnas.1525360113. Epub 2016 Apr 4.
3
Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.
癌症干细胞标志物ALDH1A3在胶质母细胞瘤中的新功能:通过旁分泌PAI-1和IL-8促进血管生成
Cancers (Basel). 2023 Sep 4;15(17):4422. doi: 10.3390/cancers15174422.
4
Intra- and Intertumoral Microglia/Macrophage Infiltration and Their Associated Molecular Signature Is Highly Variable in Canine Oligodendroglioma: A Preliminary Evaluation.犬少突胶质细胞瘤瘤内和瘤间小胶质细胞/巨噬细胞浸润及其相关分子特征高度可变:一项初步评估
Vet Sci. 2023 Jun 19;10(6):403. doi: 10.3390/vetsci10060403.
5
Targeting TRAF3IP2 inhibits angiogenesis in glioblastoma.靶向TRAF3IP2可抑制胶质母细胞瘤中的血管生成。
Front Oncol. 2022 Aug 15;12:893820. doi: 10.3389/fonc.2022.893820. eCollection 2022.
6
Generation of an Immortalized Human Adipose-Derived Mesenchymal Stromal Cell Line Suitable for Wound Healing Therapy.永生人脂肪来源间充质基质细胞系的生成适合伤口愈合治疗。
Int J Mol Sci. 2022 Aug 10;23(16):8925. doi: 10.3390/ijms23168925.
7
Differentiated glioma cell-derived fibromodulin activates integrin-dependent Notch signaling in endothelial cells to promote tumor angiogenesis and growth.分化型神经胶质瘤细胞衍生纤调蛋白激活内皮细胞中整合素依赖性 Notch 信号通路,促进肿瘤血管生成和生长。
Elife. 2022 Jun 1;11:e78972. doi: 10.7554/eLife.78972.
8
Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis.子宫内膜异位症相关血管生成及子宫内膜异位症的抗血管生成治疗
Front Glob Womens Health. 2022 Apr 5;3:856316. doi: 10.3389/fgwh.2022.856316. eCollection 2022.
9
Adapt to Persist: Glioblastoma Microenvironment and Epigenetic Regulation on Cell Plasticity.适应以求存续:胶质母细胞瘤微环境与细胞可塑性的表观遗传调控
Biology (Basel). 2022 Feb 16;11(2):313. doi: 10.3390/biology11020313.
10
Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma.晚期软骨肉瘤的治疗靶点和新兴治疗方法。
Int J Mol Sci. 2022 Jan 20;23(3):1096. doi: 10.3390/ijms23031096.
对血管生成素-2(Ang-2)和血管内皮生长因子(VEGF)受体的双重抑制通过改变巨噬细胞使胶质母细胞瘤的肿瘤血管正常化并延长生存期。
Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4470-5. doi: 10.1073/pnas.1525349113. Epub 2016 Apr 4.
4
Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma.血管生成素-2可能参与复发性胶质母细胞瘤对贝伐单抗的耐药性。
Cancer Invest. 2016;34(1):39-44. doi: 10.3109/07357907.2015.1088948. Epub 2016 Jan 6.
5
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.内皮细胞衍生的血管生成素-2是初治和贝伐单抗耐药性胶质母细胞瘤的治疗靶点。
EMBO Mol Med. 2016 Jan 1;8(1):39-57. doi: 10.15252/emmm.201505505.
6
Autocrine IL-8 promotes F-actin polymerization and mediate mesenchymal transition via ELMO1-NF-κB-Snail signaling in glioma.自分泌白细胞介素-8通过ELMO1-NF-κB-蜗牛信号通路促进胶质瘤中F-肌动蛋白聚合并介导间充质转化。
Cancer Biol Ther. 2015;16(6):898-911. doi: 10.1080/15384047.2015.1028702. Epub 2015 Apr 14.
7
VEGF regulates region-specific localization of perivascular bone marrow-derived cells in glioblastoma.VEGF 调节胶质母细胞瘤中血管周围骨髓源性细胞的区域特异性定位。
Cancer Res. 2014 Jul 15;74(14):3727-39. doi: 10.1158/0008-5472.CAN-13-3119. Epub 2014 May 12.
8
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.贝伐珠单抗联合放疗-替莫唑胺治疗新诊断的胶质母细胞瘤。
N Engl J Med. 2014 Feb 20;370(8):709-22. doi: 10.1056/NEJMoa1308345.
9
A randomized trial of bevacizumab for newly diagnosed glioblastoma.贝伐珠单抗治疗新诊断的胶质母细胞瘤的随机试验。
N Engl J Med. 2014 Feb 20;370(8):699-708. doi: 10.1056/NEJMoa1308573.
10
Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche.胶质母细胞瘤干细胞在肿瘤血管周龛中受白细胞介素-8 信号的调节。
Cancer Res. 2013 Dec 1;73(23):7079-89. doi: 10.1158/0008-5472.CAN-13-1355. Epub 2013 Oct 11.